Last reviewed · How we verify
HIV prevention package including PrEP — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HIV prevention package including PrEP (HIV prevention package including PrEP) — ANRS, Emerging Infectious Diseases.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HIV prevention package including PrEP TARGET | HIV prevention package including PrEP | ANRS, Emerging Infectious Diseases | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HIV prevention package including PrEP CI watch — RSS
- HIV prevention package including PrEP CI watch — Atom
- HIV prevention package including PrEP CI watch — JSON
- HIV prevention package including PrEP alone — RSS
Cite this brief
Drug Landscape (2026). HIV prevention package including PrEP — Competitive Intelligence Brief. https://druglandscape.com/ci/hiv-prevention-package-including-prep. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing